Inhalable Lung Cancer Drug Delivery Performs Well, Study Suggests

by | Cannabis Times

 exosomes, which were then inhaled by the mice

Inhalation May Be the Safest Route for Delivering Powerful Lung Cancer Treatment, Study Suggests

In a twist of irony, a new study from Columbia University has found that the most effective way to battle lung cancer may be through inhalation, rather than traditional methods like surgery or injections. This groundbreaking research, published in Nature Nanotechnology and online on Jan. 11, has the potential to revolutionize the way we approach cancer treatment.

Localizing Immunotherapy to Tough-to-Treat Tumors

The study, conducted on rat models, showed that an inhalable lung cancer treatment is capable of delivering localized immunotherapy to difficult-to-treat tumors. This is a major breakthrough, as researchers have been searching for a safe and non-invasive alternative to current methods that require direct injection of immunomodulators into the tumors.

Exosomes: The Key to the Next Step in Lung Cancer Treatment

Exosomes, also known as extracellular vesicles (EVs), may hold the key to the next step in lung cancer treatment. These tiny bubbles act as messengers between cells, sending and receiving information. Lead researcher Ke Cheng, PhD, professor of biomedical engineering at Columbia, has been studying exosomes for over 15 years and believes they could be the key to delivering potent drugs directly to lung cancer cells.

A Safer Delivery Route for Potent Immunotherapy

The study showed that nanobubbles containing a powerful drug could be administered via inhalation, providing a safer delivery route for potent immunotherapy. This is a major advantage, as traditional chemotherapy can have serious side effects throughout the body. Inhalation, on the other hand, is completely non-invasive and does not require needles or medical professionals.

Targeting Tumor Cells Without Harming Healthy Tissue

One of the main challenges in cancer treatment is targeting tumor cells without harming healthy tissue. This is where the use of exosomes and mRNA comes in. The study involved inserting mRNA for interleukin-12 (IL-12) into exosomes, which were then inhaled by mice with tumors. This approach has the potential to bolster systemic immunity and effectively fight cancer without causing harmful side effects.

A Promising Future for Inhalable Treatments

The study has opened up new possibilities for the therapeutic use of exosomes, inhalable treatments for lung conditions, and the safe delivery of powerful immunotherapy. With further research and development, this approach could potentially save countless lives and change the way we think about treating lung cancer.